Literature DB >> 15732282

Cytokine expression in lupus kidneys.

M Aringer1, J S Smolen.   

Abstract

Although far from complete, the picture of cytokines present in systemic lupus erythematosus (SLE) glomerulonephritis is already complex. Proinflammatory cytokines, such as TNF, IL-6, IL-1, and IL-18 are upregulated, as are both Th1 and Th2 cytokines, with different implications. In many instances, the local effects may be different from the systemic immunoregulatory ones. For some proinflammatory cytokines, and TNF in particular, the local proinflammatory ones may be more relevant to the disease. This may help solve discrepancies between different murine models of the disease and provide a better rationale for targeting certain cytokines in human SLE.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15732282     DOI: 10.1191/0961203305lu2053oa

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  30 in total

1.  Biomarkers of lupus nephritis determined by serial urine proteomics.

Authors:  Xiaolan Zhang; Ming Jin; Haifeng Wu; Tibor Nadasdy; Gyongyi Nadasdy; Nathan Harris; Kari Green-Church; Haikady Nagaraja; Daniel J Birmingham; Chack-Yung Yu; Lee A Hebert; Brad H Rovin
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

2.  Targeting the CD134-CD134L interaction using anti-CD134 and/or rhCD134 fusion protein as a possible strategy to prevent lupus nephritis.

Authors:  Yan-bin Zhou; Ren-gao Ye; You-ji Li; Can-mao Xie
Journal:  Rheumatol Int       Date:  2008-09-20       Impact factor: 2.631

3.  A protective role of Mer receptor tyrosine kinase in nephrotoxic serum-induced nephritis.

Authors:  Wen-Hai Shao; Yuxuan Zhen; Joshua Rosenbaum; Robert A Eisenberg; Tracy L McGaha; Mark Birkenbach; Philip L Cohen
Journal:  Clin Immunol       Date:  2010-05-04       Impact factor: 3.969

4.  Beneficial effect of Eucommia polysaccharides on systemic lupus erythematosus-like syndrome induced by Campylobacter jejuni in BALB/c mice.

Authors:  Long Jiang; Zheng Wang; Hong-Wei Zhu; Hong-Ye Di; Hong Li; Yun-Yi Zhang; Dao-Feng Chen
Journal:  Inflammation       Date:  2011-10       Impact factor: 4.092

5.  Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model.

Authors:  Xiaoli Mao; Yunyun Wu; Huitian Diao; Jianlei Hao; Gaofei Tian; Zhenghu Jia; Zheng Li; Sidong Xiong; Zhenzhou Wu; Puyue Wang; Liqing Zhao; Zhinan Yin
Journal:  Clin Rheumatol       Date:  2014-06-15       Impact factor: 2.980

6.  Elevated interleukin-18 and skewed Th1:Th2 immune response in lupus nephritis.

Authors:  Xiaoqian Liu; Chunde Bao; Dawei Hu
Journal:  Rheumatol Int       Date:  2010-10-21       Impact factor: 2.631

7.  Increased expression and secretion of interleukin-6 in human parvovirus B19 non-structural protein (NS1) transfected COS-7 epithelial cells.

Authors:  T-C Hsu; B-S Tzang; C-N Huang; Y-J Lee; G-Y Liu; M-C Chen; G J Tsay
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

8.  TRAIL, DR4 and DR5 are upregulated in kidneys from patients with lupus nephritis and exert proliferative and proinflammatory effects.

Authors:  Vinh Nguyen; Cornelia Cudrici; Valentina Zernetkina; Florin Niculescu; Horea Rus; Cynthia Drachenberg; Violeta Rus
Journal:  Clin Immunol       Date:  2009-04-05       Impact factor: 3.969

9.  Up-regulation of activating transcription factor-5 suppresses SAP expression to activate T cells in hemophagocytic syndrome associated with Epstein-Barr virus infection and immune disorders.

Authors:  Huai-Chia Chuang; Ju-Ming Wang; Wen-Chuan Hsieh; Yao Chang; Ih-Jen Su
Journal:  Am J Pathol       Date:  2008-10-02       Impact factor: 4.307

10.  Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.

Authors:  Hye-Young Chun; Jae-Wook Chung; Hyoun-Ah Kim; Jeong-Moon Yun; Ja-Young Jeon; Young-Min Ye; Seung-Hyun Kim; Hae-Sim Park; Chang-Hee Suh
Journal:  J Clin Immunol       Date:  2007-06-21       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.